CIK: 1263366 - Address: C/o Repligen Corporation, 41 Seyon St., Bldg 1, Ste 100, Waltham, MA 02453
25 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret11131-0-26195814
S%wins62695442252246

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/2/22 21:14
3/1/22
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS.d-396198.030-2-581D
11/4/21 17:45
11/2/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS.dm-676295.870-2-1612D
8/5/21 19:33
8/4/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS-195250.500-1-451D
3/4/21 21:22
3/3/21
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS.d-205205.000-1-411D
11/13/20 16:46
11/11/20
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS.d-175187.730-1-391D
8/4/20 19:50
7/31/20
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS.d-470151.900-3-681D
3/18/20 17:10
3/16/20
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS.d-9191.480-1-342D
3/5/20 17:53
3/3/20
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS.dm-61787.840-7-782D
11/6/18 18:29
11/5/18
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS-11665.750-2-353D
8/24/18 16:16
8/22/18
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS-12251.440-2-325D
6/7/18 16:28
6/6/18
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS-8644.310-2-217D
3/12/18 17:32
3/8/18
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS.d-17036.160-5-359D
3/22/17 16:34
3/20/17
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS.d-13934.838-4-329D5392516650225
9/16/16 13:20
9/14/16
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS-8832.588-3-229D72-83547107510-1-1106
7/1/16 16:06
6/30/16
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS-13326.608-5-2912D15-34-6214182117-3-17613
6/29/16 14:46
6/28/16
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS.d-24624.597-10-3717D10-40-14-7-21185711122729
5/12/15 08:38
5/8/15
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS-74437.1914-20-5020D31311766652518312138-1-4-31-31
3/20/15 16:50
3/19/15
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS-32632.6213-10-2040D41911671654030318-2-1132316-25
11/17/14 10:47
11/13/14
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS.d-23823.819-10-1750D34084281412-4-5-10-2-1397912
7/1/14 08:12
6/27/14
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS.d-22422.4112-10-1750D4451778077251210450-2-12-1581
6/25/14 14:04
6/24/14
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS.d-21821.7811-10-1750D3991797363217116095-10-588
6/9/14 15:56
6/5/14
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS.d-92520.5610-45-4750D40415254453115107-2-311-8887
5/20/13 12:04
5/16/13
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS.m-1888.973-21-3048M1358867363-1-50-2-4-111243106
5/16/13 14:16
5/15/13
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS-189.003-2-362D13285693812020-1-8-151240102
5/15/13 15:21
5/13/13
RGENRepligen CorpDEHealthBioPrdBiological Products, (No DiagRyan Thomas F JrMADS.dm-7759.013-86-5959D1338962352200-51-3-131640102

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact